Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.01) by 1100 percent. This is a 150 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $115.177 million which beat the analyst consensus estimate of $108.833 million by 5.83 percent. This is a 6.12 percent increase over sales of $108.530 million the same period last year.